163
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The quality of published health economic evaluations on screening programs in China: a systematic review and quantitative appraisal

, , , , , & show all
Pages 1277-1283 | Received 21 Mar 2022, Accepted 29 Sep 2022, Published online: 13 Oct 2022

References

  • Xu Y, Wei Y, Ming J, et al. Cost-effectiveness analysis of non-invasive prenatal testing for down syndrome in China [J]. Int J Technol Assess Health Care. 2019;35(3):237–242.
  • Dibosa-Osadolor O, Roberts T. Economic evaluation, human immunodeficiency virus infection and screening: a review and critical appraisal of economic studies [J]. Int J Technol Assess Health Care. 2010;26(3):301–308.
  • Shi J-F, Mao A-Y, Sun Z-X, et al. Sustainability of cancer screening in China: a multicentre assessment from the perspective of service suppliers and demanders [J]. Lancet. 2017;390:S95.
  • Evaluation. I f H M a. Graph illustration global burden of disease compare 2016. Vizhub.; 2018 [cited 2021 Mar 10]. Available from: https://vizhub.healthdata.org/gbd-compare/
  • Shi L, Mao Y, Tang M, et al. Health technology assessment in China: challenges and opportunities [J]. Global Health J. 2017;1(1): 11–20
  • Cook WA, Morrison ML, Eaton LH, et al. Quantity and quality of economic evaluations in US nursing research 1997–2015: a systematic review [J]. Nurs Res. 2017;66(1):28.
  • Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force [J]. Value Health. 2013;16(2):231–250.
  • Butt T, Liu GG, Kim DD, et al. Taking stock of cost-effectiveness analysis of healthcare in China [J]. BMJ Global Health. 2019;4(3):e001418.
  • Chen Y, Qian X, Li J, et al. Cost-effectiveness analysis of prenatal diagnosis intervention for Down’s syndrome in China [J]. Int J Technol Assess Health Care. 2007;23(1):138–145.
  • Mendlowitz AB, Naimark D, Wong WW, et al. The emergency department as a setting‐specific opportunity for population‐based hepatitis C screening: an economic evaluation [J]. Liver Int. 2020;40(6):1282–1291.
  • Kirkizlar E, Serban N, Sisson JA, et al. Evaluation of telemedicine for screening of diabetic retinopathy in the veterans health administration [J]. Ophthalmology. 2013;120(12):2604–2610.
  • Han X, Xu J, Chu Z, et al. Screening acute HIV infections among Chinese men who have sex with men from voluntary counseling & testing centers [J]. PLoS One. 2011;6(12):e28792.
  • Peng J, Zhao F, Yang C. Cost-effectiveness analysis of cervical cancer screening strategies in urban China [J]. Chinese J Oncol. 2019;41(2):154–160.
  • Zou Y, Liu F, Chen L, et al. Health economics evaluation of syphilis intervention strategy in syphilis integrated prevention and control area of Guangdong Province [J]. Chin J Dis Control Prev. 2017;21(4):409–413.
  • Yip W, Fu H, Chen AT, et al. 10 years of health-care reform in China: progress and gaps in universal health coverage [J]. Lancet. 2019;394(10204):1192–1204.
  • State Council of the People‘s Republic of China. Plan for deepening reform of the medical and healthcare system during the 13th five-year plan period. 2017 [cited 2021 Mar 10]. Available from: http://www.gov.cn/zhengce/content/2017-01/10/content_5158488.htm
  • National Health Commission of the People‘s Republic of China. Notice on the issuance of a work plan to accelerate the implementation of the policy on the security of supply and use of generic drugs 2018. [cited 2021 Mar 10]. Available from: http://www.gov.cn/zhengce/zhengceku/2018-12/31/content_5436937.htm
  • Beijing Municipal Medical Insurance Bureau. Notice on Regulating and Adjusting the Price Items of Medical Services such as Physical Therapy. 2021. cited 2021 Nov 20. Available from: http://ybj.beijing.gov.cn/zwgk/2020_zcwj/202108/t20210830_2479735.html
  • Liu P, Gu J, Bai M, et al. Quality evaluation of the literatures about medical insurance budget impact analysis in China and the United States [J]. China Pharm. 2019;30(12):1684–1691.
  • Du Y, Li C, Fang G, et al. Research and enlightenment of quality assessment scale for medical insurance drugs’ economic evaluation [J]. Health Econ Res. 2020;37(6):28–32.
  • Zhao J, Du S, Zhu Y, et al. A systematic review of health economic evaluation on targeted therapies for first-line treatment of metastatic non-small cell lung cancer (NSCLC): quality evaluation [J]. Cancer Manag Res. 2020;12:4357.
  • Evers S, Goossens M, De Vet H, et al. Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria [J]. Int J Technol Assess Health Care. 2005;21(2):240–245.
  • Drummond MF, Jefferson T. Guidelines for authors and peer reviewers of economic submissions to the BMJ [J]. Bmj. 1996;313(7052):275–283.
  • Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes [M]. 4th ed. New York: Oxford university press; 2015.
  • Wang L, Shi F, Guan X, et al. A systematic review of methods and study quality of economic evaluations for the treatment of schizophrenia [J]. Front Public Health. 2021 9 ;689123.
  • Pandey P, Pandey RD, Shah V. Evaluation of quality of pharmacoeconomic studies in Asia-Pacific region and identification of influencing variables [J]. Value Health Reg Issues. 2018;15:70–75. .
  • Ma H, Jian W, Xu T, et al. Quality of pharmacoeconomic research in China: a systematic review [J]. Medicine (Baltimore). 2016;95(41):e5114.
  • Fontenay S, Catarino L, Snoussi S, et al. Quality of economic evaluations of ventricular assist devices: a systematic review [J]. Int J Technol Assess Health Care. 2020;36(4):380–387.
  • Zhen X, Sun X, Dong H. Health technology assessment and its use in drug policies in China [J]. Value Health Reg Issues. 2018;15:138–148.
  • Si L, Xu L, Chen M, et al. Using strategic price negotiations to contain costs and expand access to medicines in China [J]. BMJ Glob Health. 2020;5(1):e002256.
  • the State Council of the People‘s Republic of China. CPC central committee and state council on deepening the health care reform. 2009. [cited 2021 Nov 4]. Available from: http://www.gov.cn/test/2009-04/08/content_1280069.htm
  • Chen Y, He Y, Chi X, et al. Development of health technology assessment in China: new challenges [J]. Biosci Trends. 2018;12(2):102–108.
  • Chen ZM, Yin WQ. Study on vulnerability of village clinic doctors in Shandong province in the context of the new medical reform[M]. Beijing: China Social Sciences Press; 2018 Sep.
  • National Health Commission of the People‘s Republic of China. Notice on national centralized drug procurement. 2015 [cited 2021 Nov 20]. Available from: http://www.nhc.gov.cn/yaozs/s3577/201605/15fb339b6b854b8981dee3306d76ce27.shtml
  • Guoen L. China guidelines for pharmacoeconomic evaluations (2020) [M]. Beijing: China Market Press; 2020.
  • Karekar S, Shetty Y. Assessment of the quality and trend of reporting of health economic evaluation research in India [J]. Expert Rev Pharmacoecon Outcomes Res. 2021;21(4):595–599.
  • Bscpharm DH, Dphil M, Augustovski F, et al. Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task force [J] Value in Health. 2022;25(1):10–31.
  • Nguyen HN, Ly KN, Vo QT. Assessing the quality of health economic evaluation research by cheers instrument: a critical literature review in Laos, Cambodia, And Myanmar [J]. J Appl Pharm Sci. 2017;7(6):222–228.
  • Zhang F, He X, Xiang W, et al. Assessment of the quality of pharmacoeconomic evaluation literature in China [J]. J Med Econ. 2017;20(5):510–517.
  • Cai Kong XF, Sun M, Zhu W. The experience of foreign quality assessment of pharmacoeconomics research and implications for China [J]. J Med Econ. 2014;9:62–65.
  • Spiegel B, Targownik LE, Kanwal F, et al. The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal[J]. Gastroenterology. 2004;127(2):403–411.
  • Neumann PJ, Sanders GD, Russell LB, et al. Cost-effectiveness in health and medicine [M]. 2nd. New York: Oxford University Press; 2017.
  • Drummond MF, Iglesias CP, Cooper NJ. Systematic reviews and economic evaluations conducted for the national institute for health and clinical excellence in the United Kingdom: a game of two halves? [J]. Int J Technol Assess Health Care. 2008;24(2):146–150.
  • Rezapour A, Jafari, A, Mirmasoudi, K et al . Quality Assessment of Published Articles in Iranian Journals Related to Economic Evaluation in Health Care Programs Based on Drummond's Checklist: A Narrative Review [J] Iran J Med Sci. 2017;42(5) 427–436.
  • Tran BX, Nong VM, Maher RM, et al. A systematic review of scope and quality of health economic evaluation studies in Vietnam [J]. PLoS One. 2014;9(8):e103825.
  • Jingjing Gao WZ, Jiang J, Liu J. Systematic review of health economics evaluation on upper gastrointestinal cancer screening in China [J]. Mod Preventive Med. 2021;48(4):5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.